Viewing Study NCT02886195


Ignite Creation Date: 2025-12-24 @ 1:21 PM
Ignite Modification Date: 2026-04-23 @ 3:55 AM
Study NCT ID: NCT02886195
Status: UNKNOWN
Last Update Posted: 2016-09-01
First Post: 2016-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC
Sponsor: Fujian Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module